Clinical Trials Directory

Trials / Unknown

UnknownNCT00622882

Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia

Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
1 Month
Healthy volunteers
Not accepted

Summary

The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bacteremia (SAB). This study will also determine if such consultations could reduce the duration of hospitalisation, recurrence and financial costs in patients with this infection.

Detailed description

Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such as endocarditis, osteomyelitis or pneumonia. Overall the outcome of patients with respect to mortality or recurrence is better in patients who have an eradicable focus and have received an appropriate antibiotic dose and duration. Also complicated bacteremia is more common in patients with * persistent bacteremia or fever * prosthetic device * new murmur * skin findings of a systemic infection Based on this evidence, an ID consultation could improve the outcomes of patients with SAB by * Advising adequate antibiotic dosage and duration * Sourcing out and counselling eradication of any focus of infection

Conditions

Interventions

TypeNameDescription
OTHERinfectious disease specialist consultationRandomised trial to determine the utility of an early Infectious disease Consultation in Staphylococcus aureus bacteremic patients ( in the first 48 hours of a positive blood culture)

Timeline

Start date
2007-10-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2008-02-25
Last updated
2014-01-07

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00622882. Inclusion in this directory is not an endorsement.